15.38
price down icon0.45%   -0.07
pre-market  プレマーケット:  15.62   0.24   +1.56%
loading
前日終値:
$15.45
開ける:
$15.34
24時間の取引高:
14.13M
Relative Volume:
1.18
時価総額:
$17.64B
収益:
$16.54B
当期純損益:
$-1.64B
株価収益率:
-10.61
EPS:
-1.45
ネットキャッシュフロー:
$749.00M
1週間 パフォーマンス:
-7.01%
1か月 パフォーマンス:
-7.57%
6か月 パフォーマンス:
-13.25%
1年 パフォーマンス:
-12.31%
1日の値動き範囲:
Value
$14.99
$15.45
1週間の範囲:
Value
$14.99
$17.24
52週間の値動き範囲:
Value
$12.46
$22.80

Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Company Profile

Name
名前
Teva Pharmaceutical Industries Ltd Adr
Name
セクター
Healthcare (1163)
Name
電話
972 (3) 914-8213
Name
住所
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
Name
職員
35,686
Name
Twitter
@TevaUSA
Name
次回の収益日
2025-01-29
Name
最新のSEC提出書
Name
TEVA's Discussions on Twitter

TEVA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.38 17.72B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
147.38 64.91B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.16 43.33B 29.98B 958.27M 5.31B 0.2964
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.66 42.36B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
294.28 12.42B 2.99B 1.21B 1.13B 25.06

Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-06 開始されました Goldman Buy
2025-05-28 開始されました Truist Buy
2025-05-12 アップグレード JP Morgan Neutral → Overweight
2024-07-10 アップグレード Argus Hold → Buy
2024-03-08 アップグレード JP Morgan Underweight → Neutral
2024-02-12 アップグレード Piper Sandler Neutral → Overweight
2024-01-23 アップグレード Jefferies Hold → Buy
2024-01-03 アップグレード Piper Sandler Underweight → Neutral
2023-12-18 開始されました HSBC Securities Buy
2023-11-27 アップグレード UBS Neutral → Buy
2023-07-06 アップグレード UBS Sell → Neutral
2023-05-25 開始されました Morgan Stanley Equal-Weight
2023-05-18 アップグレード Evercore ISI In-line → Outperform
2023-01-19 ダウングレード Jefferies Buy → Hold
2022-11-14 ダウングレード JP Morgan Neutral → Underweight
2022-11-04 ダウングレード UBS Neutral → Sell
2022-10-21 再開されました Jefferies Buy
2022-08-05 アップグレード BofA Securities Neutral → Buy
2022-06-14 再開されました UBS Neutral
2022-05-17 アップグレード BofA Securities Underperform → Neutral
2022-05-04 ダウングレード Piper Sandler Neutral → Underweight
2022-04-05 アップグレード Barclays Equal Weight → Overweight
2022-03-25 アップグレード Bernstein Mkt Perform → Outperform
2022-01-27 ダウングレード Argus Buy → Hold
2021-10-28 ダウングレード Raymond James Outperform → Mkt Perform
2021-05-04 ダウングレード UBS Buy → Neutral
2021-04-07 再開されました RBC Capital Mkts Sector Perform
2020-11-25 開始されました Oppenheimer Perform
2020-08-06 アップグレード Barclays Underweight → Equal Weight
2020-07-27 再開されました Goldman Neutral
2020-06-01 アップグレード SunTrust Hold → Buy
2020-04-24 再開されました Citigroup Neutral
2020-04-06 アップグレード UBS Neutral → Buy
2020-02-24 ダウングレード Edward Jones Hold → Sell
2019-11-12 アップグレード JP Morgan Underweight → Neutral
2019-10-17 アップグレード Gabelli & Co Hold → Buy
2019-08-07 ダウングレード Evercore ISI Outperform → In-line
2019-07-19 開始されました Wolfe Research Peer Perform
2019-07-15 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-07-10 再開されました Credit Suisse Neutral
2019-07-05 アップグレード Argus Hold → Buy
2019-06-11 開始されました Barclays Underweight
2019-06-03 アップグレード Oppenheimer Perform → Outperform
2019-05-30 ダウングレード BofA/Merrill Buy → Underperform
2019-05-28 ダウングレード UBS Buy → Neutral
2019-03-20 開始されました SunTrust Hold
2019-03-07 再開されました UBS Buy
すべてを表示

Teva Pharmaceutical Industries Ltd Adr (TEVA) 最新ニュース

pulisher
Jul 30, 2025

Teva's Pivot to Growth Strategy Underway as Innovative Portfolio Impresses and Pipeline Looks Solid - Morningstar

Jul 30, 2025
pulisher
Jul 30, 2025

Teva's Innovative Portfolio Fuels 10th Consecutive Quarter of Growth in Q2 2025; Increases 2025 Revenue Outlook for Key Innovative Products and EPS, and Reaffirms All Other Components - Ariva

Jul 30, 2025
pulisher
Jul 22, 2025

Head-To-Head Contrast: Teva Pharmaceutical Industries (NYSE:TEVA) & Taysha Gene Therapies (NASDAQ:TSHA) - Defense World

Jul 22, 2025
pulisher
Jul 18, 2025

Billionaire Stanley Druckenmiller Sold His Entire Stake in Palantir and Has Loaded Up on These 2 Exceptional Stocks for 3 Consecutive Quarters - The Motley Fool

Jul 18, 2025
pulisher
Jul 16, 2025

Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Drops -2.31%, Turning Investors Away - Stocksregister

Jul 16, 2025
pulisher
Jun 26, 2025

The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?26.06.25News - Ariva

Jun 26, 2025
pulisher
Jun 20, 2025

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Bought by Yousif Capital Management LLC - Defense World

Jun 20, 2025
pulisher
Jun 17, 2025

Can Teva- Pharmaceutical Industries Ltd. ADR Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Jun 17, 2025
pulisher
Jun 09, 2025

Stocks Generating Improved Relative Strength: Teva Pharmaceutical ADR - MSN

Jun 09, 2025
pulisher
May 29, 2025

Teva: New Long-Term Targets and Sold Pipeline Reaffirm Our Favorable Outlook; Shares Undervalued - Morningstar

May 29, 2025
pulisher
May 29, 2025

Teva: New Long-Term Targets and Solid Pipeline Reaffirm Our Favorable Outlook; Shares Undervalued - Morningstar

May 29, 2025
pulisher
May 28, 2025

TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate - Yahoo Finance

May 28, 2025
pulisher
May 27, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

May 27, 2025
pulisher
May 20, 2025

Restart of Student Loan Repayments Could Squeeze Consumer Spending and Slow Economic Growth - iHeart

May 20, 2025
pulisher
May 19, 2025

Bio/Pharmaceutical Outsourcing Report, March 2025 Edition - GlobeNewswire Inc.

May 19, 2025
pulisher
May 07, 2025

Teva Earnings: Innovation Propels Sales and Generics Show Stability in Solid Start to the Year - Morningstar

May 07, 2025
pulisher
May 05, 2025

Teva and Alvotech stocks jump on FDA approval of SELARSDI - Investing.com

May 05, 2025
pulisher
May 05, 2025

Teva and Alvotech stocks jump on FDA approval of SELARSDI By Investing.com - Investing.com Canada

May 05, 2025
pulisher
Apr 30, 2025

There Are Mixed Signals on the Chart for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) - uspostnews.com

Apr 30, 2025
pulisher
Apr 30, 2025

Digi Power X Inc (DGXX)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com

Apr 30, 2025
pulisher
Apr 29, 2025

Market Analysts see Norwegian Cruise Line Holdings Ltd [NCLH] gaining to $21. Time to buy? - dbtnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

PG&E Corp [PCG] Revenue clocked in at $24.54 billion, down -14.37% YTD: What’s Next? - dbtnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Greenwave Technology Solutions Inc [GWAV] Is Currently 12.13 above its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Performance and Fundamentals Dashboard tells a completely different story – Sete News - Sete News

Apr 29, 2025
pulisher
Apr 29, 2025

Raymond James slashes price target on Adma Biologics Inc [ADMA] – find out why. - dbtnews.com

Apr 29, 2025
pulisher
Apr 28, 2025

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: A Year of Highs and Lows - investchronicle.com

Apr 28, 2025
pulisher
Apr 28, 2025

Company’s Banking Stock: Dissecting a 37.52% Quarterly Revenue Decline Amid Growth - investchronicle.com

Apr 28, 2025
pulisher
Apr 28, 2025

NEOV’s Market Whiplash: -48.46% YTD Decline, 15.24% Rise in 30 Days - investchronicle.com

Apr 28, 2025
pulisher
Apr 28, 2025

Adagio Medical Holdings Inc (ADGM) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com

Apr 28, 2025
pulisher
Apr 25, 2025

A company insider recently sold 70,961 shares of Teva- Pharmaceutical Industries Ltd. ADR [TEVA]. Should You Sale? - knoxdaily.com

Apr 25, 2025
pulisher
Apr 24, 2025

Introducing Our Rant Against Teva- Pharmaceutical Industries Ltd. ADR - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

OS overperforms with a 2.12 increase in share price - uspostnews.com

Apr 24, 2025
pulisher
Apr 23, 2025

For Kopin Corp [KOPN], Analyst sees a rise to $2. What next? - dbtnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Market Analysts see Geron Corp [GERN] falling to $2. Time to buy? - dbtnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 5.18 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com

Apr 23, 2025
pulisher
Apr 22, 2025

The growth track for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has changed recently - Sete News

Apr 22, 2025
pulisher
Apr 22, 2025

Rezolute Inc: Weathering Stock Market Storms with 190.08M Market Cap - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Ready to Jump After Recent Trade: NIO Inc ADR (NIO) - Sete News

Apr 22, 2025
pulisher
Apr 21, 2025

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: Exploring a Year of Highs, Lows, and Trading Volume - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

ORCL’s Stock Journey: What Investors Need to Know About Oracle Corp’s Performance - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

TGB Stock Update: Taseko Mines Ltd’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

Lexicon Pharmaceuticals Inc (LXRX) Stock: A Year of Market Fluctuations - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

HESM’s latest rating updates from top analysts. - knoxdaily.com

Apr 21, 2025
pulisher
Apr 21, 2025

Analysts review Teva- Pharmaceutical Industries Ltd. ADR’s rating - knoxdaily.com

Apr 21, 2025
pulisher
Apr 16, 2025

Zacks Industry Outlook Dr. Reddy's, Sandoz And Teva Pharmaceuticals - Barchart.com

Apr 16, 2025
pulisher
Apr 16, 2025

Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals - Yahoo Finance

Apr 16, 2025
pulisher
Apr 15, 2025

3 Generic Drug Stocks to Watch Amid Trade War Jitters & Inflation Woes - Yahoo Finance

Apr 15, 2025

Teva Pharmaceutical Industries Ltd Adr (TEVA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$294.28
price up icon 7.13%
$128.91
price up icon 0.53%
drug_manufacturers_specialty_generic RDY
$13.94
price down icon 1.97%
$8.81
price up icon 0.80%
$13.79
price up icon 0.80%
大文字化:     |  ボリューム (24 時間):